Log in to save to my catalogue

Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in s...

Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in s...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262507

Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle

About this item

Full title

Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle

Publisher

United States: American Society for Clinical Investigation

Journal title

The Journal of clinical investigation, 2021-04, Vol.131 (8)

Language

English

Formats

Publication information

Publisher

United States: American Society for Clinical Investigation

More information

Scope and Contents

Contents

Aberrant lipid metabolism promotes the development of skeletal muscle insulin resistance, but the exact identity of lipid-mediated mechanisms relevant to human obesity remains unclear. A comprehensive lipidomic analysis of primary myocytes from individuals who were insulin-sensitive and lean (LN) or insulin-resistant with obesity (OB) revealed seve...

Alternative Titles

Full title

Lysophospholipid acylation modulates plasma membrane lipid organization and insulin sensitivity in skeletal muscle

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262507

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8262507

Other Identifiers

ISSN

0021-9738

E-ISSN

1558-8238

DOI

10.1172/JCI135963

How to access this item